CI
RGEN icon

Clal Insurance’s Repligen RGEN Stock Holding History

Clal Insurance’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7K Buy
59
+19
+48% +$2.65K ﹤0.01% 197
2025
Q4 		$7K Sell
40
-42
-51% -$6.58K ﹤0.01% 203
2025
Q3 		$11K Buy
+82
New +$9.96K ﹤0.01% 193

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Clal Insurance's RGEN Position: Q1 2026 in Review

Clal Insurance increased its Repligen (RGEN) stake by 48% in Q1 2026, buying an estimated $2.65K and bringing the position to 59 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #197.

Clal Insurance first reported a position in RGEN in Q3 2025 and has held it in 3 quarters since. The position peaked at $11K in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Clal Insurance held 59 shares of Repligen worth $7K as of Q1 2026.
  • Clal Insurance bought 19 Repligen shares in Q1 2026, an estimated $2.65K.
  • Repligen made up ﹤0.01% of Clal Insurance's portfolio in Q1 2026, its #197 holding.
  • Clal Insurance first reported a position in Repligen in Q3 2025 and has held it in 3 quarters since.
  • Clal Insurance's Repligen position peaked at $11K in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Clal Insurance's 13F filing for Q1 2026, filed 12 May 2026.